Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MEN1”

240 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 240 results

Not applicableStudy completedNCT04267263
What this trial is testing

A Novel Approach to Reducing Adiposity Among Young Men

Who this might be right for
Weight LossMenLifestyle Risk Reduction+2 more
Virginia Commonwealth University 35
Not applicableStudy completedNCT01928134
What this trial is testing

The Efficacy of Vitamin K2 n Human Osteoporosis, Blood-vessel Calcification and Sclerosis

Who this might be right for
Healthy
Changhua Christian Hospital 60
Early research (Phase 1)Study completedNCT05061563
What this trial is testing

Learn How a Proton Pump Inhibitor Affects the Way Elinzanetant (BAY 3427080) Moves Into, Through and Out of the Body, and How Much of it Gets Absorbed by the Body When Taken as a Single and Small Radioactive Dose in Healthy Adults

Who this might be right for
Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and MenHot Flashes
Bayer 14
Early research (Phase 1)Study completedNCT05071729
What this trial is testing

Learn How Elinzanetant Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Kidneys That do Not Work as Well as They Should Compared to Participants Whose Kidneys Work Normally

Who this might be right for
Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men
Bayer 31
Testing effectiveness (Phase 2)Looking for participantsNCT07356154
What this trial is testing

Revumenib and Mezigdomide in People With Leukemia

Who this might be right for
LeukemiaAcute LeukemiaRelapse Leukemia+5 more
Memorial Sloan Kettering Cancer Center 52
Not applicableStudy completedNCT03046641
What this trial is testing

Exercise Duration Models, in Middle-aged Men

Who this might be right for
Weight Loss
P.L.Shupik National Medical Academy of Post-Graduate Education 82
Large-scale testing (Phase 3)Looking for participantsNCT07444723
What this trial is testing

Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors

Who this might be right for
Primary HyperparathyroidismParathyroid CancerMultiple Endocrine Neoplasias+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 193
Testing effectiveness (Phase 2)Looking for participantsNCT06284486
What this trial is testing

A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib

Who this might be right for
Acute Myeloid Leukemia
M.D. Anderson Cancer Center 8
Not applicableStudy completedNCT02932384
What this trial is testing

Reducing HIV Risk With High Risk HIV Negative Black MSM-Passport to Wellness

Who this might be right for
HIVMen
Charles Drew University of Medicine and Science 105
Not applicableStudy completedNCT03339154
What this trial is testing

Metabolic Availability of Methionine From Chickpeas in Adult Men

Who this might be right for
Healthy
The Hospital for Sick Children 6
Not applicableStudy completedNCT06629220
What this trial is testing

Co-creation of Tools for Men With Suicidal Thoughts and/or Behavior

Who this might be right for
Suicide PreventionSuicidal IdeationSuicidal Behaviour
University Ghent 13
Testing effectiveness (Phase 2)Study completedNCT02101918
What this trial is testing

Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Multiple Endocrine Neoplasia Type 1Pancreatic Neuroendocrine Carcinoma
National Cancer Institute (NCI) 22
Early research (Phase 1)Not Yet RecruitingNCT07355335
What this trial is testing

Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML

Who this might be right for
KMT2A-rearrangedNPM1-mutant Refractory or Relapsed AML
Massachusetts General Hospital 24
Testing effectiveness (Phase 2)Looking for participantsNCT04988555
What this trial is testing

Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Lymphocytic, AcuteMultiple Myeloma+1 more
Sumitomo Pharma America, Inc. 606
Early research (Phase 1)Looking for participantsNCT05735184
What this trial is testing

Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Who this might be right for
Acute Myeloid LeukemiaMixed Lineage Leukemia Gene MutationRefractory AML+7 more
Kura Oncology, Inc. 420
Not applicableUnknownNCT04295057
What this trial is testing

Register of Therapeutical Patients Over 60 Years

Who this might be right for
MenAge ProblemTherapeutic Alliance
Eurasian Association of Therapists 12,000
Not applicableUnknownNCT04878601
What this trial is testing

Innovative Strategies to Increase ART Initiation and Viral Suppression Among HIV-positive Men in Malawi

Who this might be right for
Hiv
University of California, Los Angeles 470
Not applicableLooking for participantsNCT07627568
What this trial is testing

Analysis of Biomarkers in Patients With Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation Treated With Menin Inhibition.

Who this might be right for
Acute Myeloid Leukemia
University of Freiburg 20
Post-approval studies (Phase 4)Study completedNCT05631795
What this trial is testing

Study to Assess the Safety of Alpelisib Plus Fulvestrant, in Men and Post-menopausal Women With HR-positive, HER2-negative, Advanced Breast Cancer (aBC) With PIK3CA Mutation, Whose Disease Progressed on or After Endocrine Treatment

Who this might be right for
Advanced Breast Cancer
Novartis Pharmaceuticals 40
Not applicableStudy completedNCT00412633
What this trial is testing

Clinical & Web-based Diet & Activity Counseling for Men

Who this might be right for
Obesity
University of California, San Diego 442
Next Page